U.S. judge rejects Amgen injunction bid against Novartis Sandoz unit
March 19, 2015 at 15:19 PM EDT
SAN FRANCISCO, March 19 (Reuters) - A U.S. judge on Thursday denied Amgen Inc's bid for a preliminary injunction against Novartis AG's Sandoz unit over disputed biologic product filgrastim.
